NLRX1 and metabolic dysfunction-associated steatotic liver disease: Deletion of NLRX1 increased mitochondrial fatty acid-dependent oxidative phosphorylation (OXPHOS), decreased glycolysis in hepatocytes and protected against diet-induced metabolic syndrome and non-alcoholic fatty liver disease (NAFLD) development [35].